U.S. Physical Therapy, Inc. (USPH) Shares Bought by Atria Investments LLC

Atria Investments LLC grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 35.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,045 shares of the company’s stock after buying an additional 1,055 shares during the period. Atria Investments LLC’s holdings in U.S. Physical Therapy were worth $480,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of USPH. Acadian Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the second quarter worth $106,000. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy in the second quarter worth $219,000. Itau Unibanco Holding S.A. acquired a new stake in shares of U.S. Physical Therapy in the second quarter worth $235,000. PNC Financial Services Group Inc. increased its stake in shares of U.S. Physical Therapy by 62.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock worth $256,000 after acquiring an additional 1,031 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of U.S. Physical Therapy in the second quarter worth $257,000. 98.17% of the stock is owned by institutional investors and hedge funds.

A number of research firms have recently weighed in on USPH. ValuEngine upgraded shares of U.S. Physical Therapy from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 26th. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 price objective on the stock in a research note on Tuesday, August 7th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $105.00 price objective on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Five equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $108.00.

NYSE:USPH opened at $109.45 on Friday. The firm has a market capitalization of $1.50 billion, a PE ratio of 52.62, a price-to-earnings-growth ratio of 4.20 and a beta of 1.12. U.S. Physical Therapy, Inc. has a 1-year low of $64.38 and a 1-year high of $129.65. The company has a current ratio of 2.06, a quick ratio of 2.06 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 2nd. The company reported $0.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.05. The firm had revenue of $115.10 million for the quarter, compared to analyst estimates of $111.77 million. U.S. Physical Therapy had a net margin of 5.03% and a return on equity of 13.81%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 earnings per share. Research analysts predict that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current fiscal year.

In related news, Director Mark J. Brookner sold 4,375 shares of the firm’s stock in a transaction on Thursday, August 23rd. The shares were sold at an average price of $116.82, for a total transaction of $511,087.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Glenn Mcdowell sold 6,204 shares of the firm’s stock in a transaction on Friday, August 3rd. The shares were sold at an average price of $114.81, for a total transaction of $712,281.24. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,054 shares of company stock worth $3,713,012. 2.50% of the stock is owned by company insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also: What is a Stop Order?

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply